Migrating glioma cells express stem cell markers and give rise to new tumors upon xenografting
Glioblastoma (GBM) is the most frequent and malignant brain tumor with an overall survival of only 14.6 months. Although these tumors are treated with surgery, radiation and chemotherapy, recurrence is inevitable. A critical population of tumor cells in terms of therapy, the so-called cancer stem ce...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer US
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069331/ |